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Background: Zinc oxide nanoparticles (ZnO NPs) have received much attention for their 
implications in cancer therapy. It has been reported that ZnO NPs induce selective killing of 
cancer cells. However, the underlying molecular mechanisms behind the anticancer response 
of ZnO NPs remain unclear.
Methods and results: We investigated the cytotoxicity of ZnO NPs against three types of 
cancer cells (human hepatocellular carcinoma HepG2, human lung adenocarcinoma A549, and 
human bronchial epithelial BEAS-2B) and two primary rat cells (astrocytes and hepatocytes). 
Results showed that ZnO NPs exert distinct effects on mammalian cell viability via killing of 
all three types of cancer cells while posing no impact on normal rat astrocytes and hepatocytes. 
The toxicity mechanisms of ZnO NPs were further investigated using human liver cancer 
HepG2 cells. Both the mRNA and protein levels of tumor suppressor gene p53 and apoptotic 
gene bax were upregulated while the antiapoptotic gene bcl-2 was downregulated in ZnO NP-
treated HepG2 cells. ZnO NPs were also found to induce activity of caspase-3 enzyme, DNA 
fragmentation, reactive oxygen species generation, and oxidative stress in HepG2 cells.
Conclusion: Overall, our data demonstrated that ZnO NPs selectively induce apoptosis in 
cancer cells, which is likely to be mediated by reactive oxygen species via p53 pathway, through 
which most of the anticancer drugs trigger apoptosis. This study provides preliminary guidance 
for the development of liver cancer therapy using ZnO NPs.
Keywords: ZnO nanoparticles, cancer therapy, p53, apoptosis, ROS
Introduction
Nanotechnology allows the manipulation of materials at nanoscale level (1–100 nm), 
which enables precision engineering to control nanoparticles’ (NPs’) physicochemi-
cal properties, as well as their interactions with biological systems.1,2 Inorganic NPs, 
including metal oxides, are promising materials for applications in medicine, such as 
cell imaging, biosensing, drug/gene delivery, and cancer therapy.3–5 Zinc oxide (ZnO) 
NPs belonging to a group of metal oxides are characterized by their photocatalytic and 
photo-oxidizing ability against chemical and biological species.
In recent times, ZnO NPs have received much attention for their implications 
in cancer therapy.6 Studies have shown that ZnO NPs induce cytotoxicity in a cell-
specific and proliferation-dependent manner, with rapidly dividing cancer cells being 
the most susceptible, and quiescent cells being the least sensitive.7–9 Clearly, the type 
of cell in question is important when considering the cytotoxicity of ZnO NPs toward 
mammalian cells. To date, however, the anticancer activity of ZnO NPs, especially 
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the underlying mechanisms of apoptosis in cancer cells due 
to ZnO NP treatment, is largely lacking.
Apoptosis is a key process in cancer development and 
progression. The ability of cancer cells to avoid apoptosis and 
continue to propagate is one of the fundamental hallmarks of 
cancer and is a major target of cancer treatment. Apoptosis is 
controlled by a large number of genes acting as death switches. 
The tumor suppressor gene p53 is regarded as the master guard-
ian of the cell and is able to activate cell-cycle checkpoints, 
DNA repair, and apoptosis to maintain genomic stability.10 In 
the presence of DNA damage, p53 protein triggers cell-cycle 
arrest to provide time for the damage to be repaired or for self-
mediated apoptosis.11,12 The bax/bcl-2 protein ratio determines 
the life or death of cells in response to an apoptotic stimulus. 
A higher level of bax/bcl-2 ratio decreases the resistance to 
apoptotic stimuli, leading to apoptosis.13 The bcl-2 protein has 
an antiapoptotic effect, whereas the bax is known for proapop-
totic activity. It has also been well documented that signaling 
pathway leading to apoptosis involves the sequential activation 
of cysteine proteases known as caspases.14,15
This study was designed to investigate the cytotoxicity of 
well-characterized ZnO NPs against three types of cancer cells 
(human hepatocellular carcinoma HepG2, human lung adeno-
carcinoma A549, and human bronchial epithelial BEAS-2B) 
and two primary rat cells (astrocytes and hepatocytes). These 
cell lines have been extensively utilized in toxicity studies.16–19 
To explore the underlying molecular mechanisms of apoptosis 
induced by ZnO NPs, we have further utilized the human 
liver cancer HepG2 cells. Quantitative real-time polymerase 
chain reaction (PCR) and Western blotting techniques were 
used to determine both the mRNA and protein levels of 
p53, bax, bcl-2, and caspase-3 genes involved in apoptotic 
pathways. Reactive oxygen species (ROS) generation and 
oxidative stress have been proposed as common mediators 
for apoptosis.20–22 Therefore, levels of ROS, lipid peroxida-
tion (LPO), and glutathione (GSH), along with the activity of 
antioxidant enzymes, were determined. HepG2 cell line was 
selected because hepatocellular carcinoma is a major health 
problem, accounting for more than 626,000 new cases per year 
worldwide.23 This cell line has been widely used as a human 
liver model in the development of new anticancer drugs.24,25
Materials and methods
Reagents
Fetal bovine serum, penicillin-streptomycin, DMEM/
F-12 medium, RPMI1640 medium and Dulbecco   phosphate 
buffered saline were purchased from Invitrogen Co, 
(Carlsbad, CA). MTT (3-(4,5-dimethylthiazol-2-yl)-2, 
5-diphenyltetrazoliumbromide), GSH, 5,5-dithio-bis-(2-
nitrobenzoic acid) (DTNB), thiobarbituric acid (TBA), 2,7-
dichlorofluorescin diacetate (DCFH-DA), anti-p53 antibody, 
anti-bax antibody, anti-bcl-2 antibody, and anti-β-actin 
antibody were obtained from Sigma-Aldrich (St Louis, MO). 
Secondary antibodies, RIPA buffer, and sodium dodecyl 
sulfate (SDS) were bought from Santa Cruz Biotechnology, 
Inc, (Santa Cruz, CA). All other chemicals used were of the 
highest purity available from commercial sources.
Synthesis of ZnO NPs
ZnO NPs were prepared by the coprecipitation technique using 
highly pure zinc acetate dihydrate (Zn[CH3COO]2.2H2O, 
99%–100%, Merck Chemicals, Darmstadt, Germany) as a 
precursor with sodium hydroxide solution, as described in 
our previous publication.26
Characterization of ZnO NPs
The optical absorption of the ZnO NP suspension was 
measured using a double-beam ultraviolet-visible (UV-Vis) 
spectrum (Shimadzu-2550, Kyoto, Japan) in the wavelength 
range of 200–800 nm at room temperature. The crystalline 
nature of ZnO NPs was carried out by X-ray diffraction 
(XRD) pattern. The XRD pattern of ZnO nanopowder was 
acquired at room temperature with the help of a PANalyti-
cal X’Pert X-ray diffractometer equipped with an Ni filtered 
using Cu Kα (λ = 1.54056 Å) radiations as an X-ray source. 
Structural studies of ZnO NPs were done by field emission 
scanning electron microscope (JSM-7600F, JEOL Inc, 
Akishima, Japan) and field emission transmission electron 
microscopy (JEM-2100F, JEOL Inc,) at an accelerating volt-
age of 15 kV and 200 kV , respectively. Energy-dispersive 
X-ray spectroscopy (EDS) was utilized to determine the 
elemental composition (purity) of ZnO NPs.
The average hydrodynamic size and zeta potential 
of ZnO NPs in water and complete cell culture medium 
were determined by dynamic light scattering (DLS) 
(Nano-  ZetaSizer-HT, Malvern Instruments, Malvern, UK) as 
described by Murdock et al.27 The ZnO NPs were dispersed 
in water and complete cell culture medium (DMEM) at a 
concentration of 15 µg/mL for 24 hours. Then, the suspension 
was sonicated using a sonicator bath at room temperature for 
15 minutes at 40 W and the DLS experiments performed.
Cell culture and exposure with ZnO NPs
Three types of cancer cells (HepG2, A549, and BEAS-2B) 
and two primary rat cells (astrocytes and hepatocytes) were 
used to determine the cell viability against ZnO NP   exposure. 
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Human hepatocellular carcinoma (HepG2) and human bron-
chial epithelial cells (BEAS-2B) were obtained from American 
Type Culture Collection (ATCC) (Manassas, VA). Human 
lung adenocarcinoma (A549) was bought from National Centre 
for Science (NCCS) (Pune, India). Rat hepatocytes and astro-
cytes were isolated by collagenase perfusion technique using 
the method of Moldeus28 and Tanaka et al,29 respectively.
Cells were cultured in DMEM/F-12 or RPMI 1640 medium 
supplemented with 10% fetal bovine serum and 100 U/mL pen-
icillin-streptomycin at 5% CO2 and 37°C. At 85% confluence, 
cells were harvested using 0.25% trypsin and were subcultured 
into 75 cm2 flasks and six-well plates or 96-well plates accord-
ing to selection of experiments. Cells were allowed to attach 
to the surface for 24 hours prior to   treatment. ZnO NPs were 
suspended in cell culture medium and diluted to appropriate 
concentrations (5 µg/mL, 10 µg/mL, and 15 µg/mL). The 
dilutions of ZnO NPs were then sonicated using a sonicator 
bath at room temperature for 10 minutes at 40 W to avoid NP 
agglomeration prior to cell exposure. Following treatment, 
cells were harvested to determine cytotoxicity, oxidative stress, 
and apoptosis markers. Cells not exposed to ZnO NPs served 
as controls in each experiment. Selection of a 5–15 µg/mL 
dosage range of ZnO NPs was based on a preliminary dose-
response study (data not shown).
Cell viability assay
Viability of HepG2, A549, BEAS-2B, and primary rat cells 
(hepatocytes and astrocytes) was assessed by the MTT assay 
as described by Mossman,30 with some modifications.15 
Briefly, 1 × 104 cells/well were seeded in 96-well plates 
and exposed to ZnO NPs at the concentrations of 0 µg/mL, 
5 µg/mL, 10 µg/mL, and 15 µg/mL for 24 hours. At the end 
of exposure, culture medium was removed from each well 
to avoid interference of ZnO NPs and replaced with new 
medium containing MTT solution (0.5 mg/mL) in an amount 
equal to 10% of culture volume and incubated for 3 hours 
at 37°C until a purple-colored formazan product developed. 
The resulting formazan product was dissolved in acidified 
isopropanol. Further, the 96-well plate was centrifuged at 
2300 × g for 5 minutes to settle the remaining ZnO NPs. Then, 
a 100 µL supernatant was transferred to other fresh wells of 
a 96-well plate, and absorbance was measured at 570 nm by 
a microplate reader (FLUOstar Omega, Cary, NC).
Total RNA isolation and quantitative real-
time PCR analysis for apoptotic markers
Human liver cancer HepG2 cells were cultured in six-well 
plates and exposed to 15 µg/mL ZnO NPs for 24 hours. At the 
end of exposure, total RNA was extracted by RNeasy mini Kit 
(Qiagen,Valencia, CA, USA) according to the manufacturer’s 
instructions. Concentration of the extracted RNA was deter-
mined using Nanodrop 8000 spectrophotometer (Thermo-
Scientific, Wilmington, DE), and the integrity of RNA was 
visualized on a 1% agarose gel using a gel documentation 
system (Universal Hood II, BioRad, Hercules, CA). The first 
strand of cDNA was synthesized from 1 µg of total RNA by 
reverse transcriptase using M-MLV (Promega, Madison, WI) 
and oligo (dT) primers (Promega) according to the manufac-
turer’s protocol. Quantitative real-time PCR was performed 
by QuantiTect SYBR Green PCR kit (Qiagen) using an 
ABI PRISM 7900HT Sequence Detection System (Applied 
Biosystems, Foster City, CA). Two microliters of template 
cDNA was added to the final volume of 20 µL of reaction 
mixture. Real-time PCR cycle parameters included 10 min-
utes at 95°C followed by 40 cycles involving denaturation 
at 95°C for 15 seconds, annealing at 60°C for 20 seconds, 
and elongation at 72°C for 20 seconds. The sequences of the 
specific sets of primer for p53, bax, bcl-2, caspase-3, and 
β-actin used in this study are given in our previous publica-
tion.15   Expressions of selected genes were normalized to the 
β-actin gene, which was used as an internal housekeeping 
control. All the real-time PCR experiments were performed 
in triplicate, and data were expressed as the mean of at least 
three independent experiments.
Western blotting
Human liver cancer HepG2 cells were cultured in six-well 
plates and exposed to ZnO NPs at the concentration of 
15 µg/mL for 24 hours. The harvested cell pellets were 
lysed in RIPA lysis buffer (1X TBS [0.5 MTris-HCl and 
1.5 MNaCl] pH 7.4, 1% NP-40, 0.5% sodium deoxycholate, 
0.1% SDS, 0.004% sodium azide) in the presence of a pro-
tease inhibitor. The cell lysates were then analyzed for protein 
content using SDS-Page immunoblotting. The membrane was 
then probed with p53, bax, bcl-2, and β-actin antibodies to 
determine the expression of proteins.
Caspase-3 assay
Activity of caspase-3 enzyme was determined using a 
standard fluorometric microplate assay.31 In brief, 1 × 104 
HepG2 cells/well were seeded in a 96-well plate and exposed 
to ZnO NPs at the concentration of 15 µg/mL for 24 hours. 
After the exposure was complete, cells were harvested in ice-
cold phosphate buffer saline and prepared cell lysate. Further, 
a reaction mixture containing 30 µL of cell lysate, 20 µL of 
Ac-DEVDAFC (caspase-3 substrate), and 150 µL of protease 
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reaction buffer (50 mM Hepes, 1 mM EDTA, and 1 mM DTT) 
(pH 7.2) was incubated for 15 minutes. The fluorescence of 
the reaction mixture was measured at 5-minute intervals for 
15 minutes at excitation/emission wavelengths of 430/535 nm 
using a microplate reader (FLUOstar Omega). 7-amido-4-
trifluoromethylcoumarin (AFC) standard ranging from 5 µM 
to 15 µM was prepared, and its fluorescence was recorded 
for calculation of caspase-3 activity in terms of pmol AFC 
released/minute/mg protein.
Apoptotic DNA ladder assay
Apoptotic DNA ladder assay was performed in HepG2 cells 
exposed to 15 µg/mL ZnO NPs for 24 hours. At the end of 
exposure, DNA was extracted using an apoptotic DNA Lad-
der Kit (Roche, Indianapolis, IN, Cat No. 11835246001). 
The extracted DNA was then evaluated on a 1% agarose gel 
using ethidium bromide. DNA fragmentation pattern was 
documented by a gel documentation system.
Measurement of intracellular ROS
Intracellular production of ROS was measured using 2, 
7-dichlorofluorescein diacetate (DCFH-DA).32 The DCFH-
DA passively enters the cell, where it reacts with ROS to form 
the highly fluorescent compound dichlorofluorescein (DCF). 
In brief, 10 mM DCFH-DA stock solution (in methanol) was 
diluted in culture medium without serum or another addi-
tive to yield a 100 µM working solution. HepG2 cells were 
treated with ZnO NPs at the concentration of 15 µg/mL for 
24 hours. At the end of exposure, cells were washed twice 
with HBSS and then incubated in 1 mL of working solution 
of DCFH-DA at 37°C for 30 minutes. Cells were lysed in 
alkaline solution and centrifuged at 2300 × g for 10 minutes. 
A 200 µL supernatant was transferred to a 96-well plate, and 
fluorescence was measured at 485 nm excitation and 520 nm 
emission using a microplate reader (FLUOstar Omega). The 
values were expressed as a percent of fluorescence intensity 
relative to control wells.
Assays of oxidative stress parameters
HepG2 cells were cultured in a 75 cm2 culture flask and exposed 
to ZnO NPs at the concentration of 15 µg/mL for 24 hours. 
After the treatment, cells were washed and harvested in ice-
cold phosphate buffer saline at 4°C. The harvested cell pellets 
were then lysed in cell lysis buffer (20 mM Tris-HCl [pH 7.5], 
150 mM NaCl, 1 mM Na2EDTA, 1% Triton and 2.5 mM 
sodium pyrophosphate). Following centrifugation (10,000 × g 
for 10 minutes at 4°C), the supernatant (cell extract) was main-
tained on ice until assayed for oxidative stress biomarkers.
The extent of membrane LPO was estimated by mea-
suring the formation of malondialdehyde (MDA) using 
the method of Ohkawa et al.33 MDA is one of the products 
of membrane LPO. A mixture of 0.1 mL cell extract and 
1.9 mL of 0.1 M sodium phosphate buffer (pH 7.4) was 
incubated at 37°C for 1 hour. The incubation mixture, after 
precipitation with 5% TCA, was centrifuged (2300 × g 
for 15 minutes at room temperature) and the supernatant 
  collected. Then, 1.0 mL of 1% TBA was added to the super-
natant and placed in the boiling water for 15 minutes. After 
cooling to room temperature, absorbance of the mixture 
was taken at 532 nm and expressed in nmol/mg protein 
using molar extinction coefficient of 1.56 × 105 M-1 cm-1. 
GSH level was quantified using Ellman’s reagent.34 The 
assay mixture consisted of phosphate buffer, DTNB, and 
cell extract. The reaction was monitored at 412 nm, and the 
amount of GSH was expressed in terms of nmol/mg protein. 
Superoxide dismutase (SOD) activity was estimated by 
employing a method described earlier.35 The assay mixture 
contained sodium pyrophosphate buffer, nitrobluetetrazo-
lium (NBT), phenazine methosulphate (PMS), reduced 
nicotinamide adenine dinucleotide (NADH), and the 
required volume of cell extract. One unit of SOD enzyme 
activity is defined as the amount of enzyme required for 
inhibiting the chromogen production (optical density at 
560 nm) by 50% in 1 minute under assay conditions and 
expressed as specific activity in units/mg protein. Catalase 
(CAT) activity was measured by following its ability to split 
hydrogen peroxide (H2O2) within 1 minute of incubation 
time. The reaction was then stopped by adding dichromate/
acetic acid reagent, and the remaining H2O2 was determined 
by measuring chromic acetate at 570 nm, which is formed 
by reduction of dichromate/acetic acid in the presence 
of H2O2, as described earlier.36 The specific activity of 
CAT was expressed as unit/mg protein. GSH reductase 
(GR) activity was measured by following the oxidation of 
NADPH to NADP+ during the reduction of oxidized GSH 
(GSSG).37 GR activity was expressed as nmol NADPH/
minute/mg protein. Activity of GSH peroxidise (GPx) was 
examined by coupling the reduction of peroxides with GSH 
and recycling of GSSG by GR in excess using NADPH as 
a cofactor.38 GPx activity was expressed as nmol NADPH/
minute/mg protein.
Estimation of protein
The total protein content was measured by the Bradford 
method39 using Bradford reagent (Sigma-Aldrich) and bovine 
serum albumin as the standard.
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Statistical analysis
Statistical significance was determined by one-way analysis 
of variance followed by Dunnett’s multiple comparison test. 
Significance was ascribed at P , 0.05. All analyses were 
conducted using the Prism software package (GraphPad 
Software, Version 5.0, GraphPad Software Inc., San Diego, 
CA).
Results
Characterization of ZnO NPs
The UV-Vis spectrum showed a sharp absorption band at 
367 nm (Figure 1). The band-gap energy calculated accord-
ing to the Mott model40 was 3.32 eV . The crystal structure of 
ZnO NPs was characterized by XRD (PANalytical X’Pert Pro 
X-ray diffractometer) with Cu Kα radiation (λ = 0.15418 nm). 
Figure 2 shows XRD patterns of ZnO NPs. The peaks at 
2θ = 31.67°, 34.31°, 36.14°, 47.40°, 56.52°, 62.73°, 66.28°, 
67.91°, 69.03°, and 72.48° were assigned to (100), (002), 
(101), (102), (110), (103), (200), (112), (201), and (004) of 
ZnO NPs, indicating that the samples were polycrystalline 
wurtzite structure (Zincite, JCPDS 5-0664). No characteristic 
peaks of any impurities were detected, suggesting that high-
quality ZnO NPs were synthesized. The average crystallite 
size (d) of ZnO NPs was estimated by Scherrer’s formula:41
d
k
=
λ
βθ cos
where k = 0.9 is the shape factor, λ is the X-ray wavelength 
of Cu Kα radiation (1.54 Å), θ is the Bragg diffraction angle, 
and β is the full width at half maximum of the respective 
diffraction peak.
The average crystallite size of ZnO NPs was found to be 
21.59 ± 4.89 nm. Figure 3A and B show the typical scan-
ning electron microscopy (SEM) and transmission electron 
microscopy (TEM) images of the ZnO NPs, respectively. 
These pictures exhibit that the majority of the particles 
were a polygonal shape with smooth surfaces. TEM average 
diameter was calculated from measuring over 100 particles 
in random fields of TEM view. The average TEM diameter 
of ZnO NPs was 21.34 ± 7.67 nm, supporting the XRD 
data. Figure 3C represents the frequency of size (nm) dis-
tribution of ZnO NPs. EDS spectrum of ZnO NPs is given 
in Figure 3D. The EDS result shows that there are no other 
elemental impurities present in the synthesized ZnO NPs. The 
presence of C and Cu signals was from the carbon-coated 
copper TEM grid used in the experiment.
The average hydrodynamic size of ZnO NPs in water 
and cell culture media determined by DLS was 131 nm and 
127 nm, respectively. Further, the zeta potential of ZnO 
NPs in water and culture media was -31 mV and -33 mV , 
respectively (Table 1).
Selective killing of cancer cells  
by ZnO NPs
Three types of cancer cells (HepG2, A549, and BEAS-2B) 
and two types of normal rat cells (astrocytes and hepatocytes) 
were exposed to ZnO NPs at the concentrations of 0 µg/mL, 
5 µg/mL, 10 µg/mL, and 15 µg/mL for 24 hours, and cyto-
toxicity was determined using MTT assay (Figure 4). Results 
have shown that ZnO NPs up to the concentration of 5 µg/mL 
did not produce a significant reduction in viability of all four 
types of cancer cells (P . 0.05 for each). As the concentration 
of NPs increased to 10 µg/mL and 15 µg/mL, a significant 
reduction in cell viability was observed for all cancer cells in 
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a dose-dependent manner (P , 0.05 for each). At 15 µg/mL, 
cell viability was significantly decreased to 33%, 39%, and 
47% for the BEAS-2B, HepG2, and A549 cells, respectively 
(P , 0.05 for each). However, ZnO NPs did not induce a sig-
nificant reduction in the viability of primary rat astrocytes and 
hepatocytes up to the maximum concentration (15 µg/mL) 
used in this study (Figure 4).
ZnO NPs altered the expression  
of mRNA levels of apoptotic genes  
in human liver cancer hepg2 cells
Quantitative real-time PCR was used to analyze the mRNA 
levels of apoptotic genes (p53, bax, bcl-2, and caspase-3) 
in HepG2 cells exposed to ZnO NPs at the concentration 
of 15 µg/mL for 24 hours. Results showed that ZnO NPs 
significantly altered the expression levels of mRNA of these 
genes in HepG2 cells. The mRNA expression level of tumor 
suppressor gene p53 (Figure 5A) and proapoptotic gene bax 
(Figure 5B) were significantly upregulated while the expres-
sion of antiapoptotic gene bcl-2 (Figure 5C) was significantly 
downregulated in ZnO NP-treated cells as compared with the 
untreated control cells. We further observed that the mRNA 
expression of caspase-3 enzyme, another marker of apoptosis, 
was significantly higher in ZnO NP-treated cells than those of 
the untreated control cells (Figure 5D) (P , 0.05 for each).
ZnO NPs altered the expression  
of protein levels of apoptotic genes  
in human liver cancer hepg2 cells
To confirm the quantitative real-time PCR results, we further 
examined the expression of protein levels in ZnO NP-exposed 
HepG2 cells using immunoblotting. Similar to mRNA 
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Figure 3 Electron microscopy characterization of zinc oxide nanoparticles. (A) Field emission scanning electron microscope image, (B) field emission transmission electron 
microscopy image (inset with higher magnification), (C) frequency of size distribution, and (D) energy-dispersive X-ray spectroscopy spectrum.
Table 1 Dynamic light scattering characterization of zinc oxide 
nanoparticles
Water Culture medium
hydrodynamic size (nm) 131 127
Zeta potential (–mV) 31 33
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results, the protein levels of p53 and bax were significantly 
upregulated while the expression of bcl-2 was significantly 
downregulated in ZnO NP-treated cells (Figure 6A and B) 
(P , 0.05 for each). Activity of caspase-3 enzyme was also 
significantly higher in ZnO NP-exposed cells compared with 
in control cells (Figure 6C) (P , 0.05).
ZnO NPs induced apoptotic DNA 
fragmentation in human liver cancer 
hepg2 cells
The DNA profiles of the cells treated with 15 µg/mL of ZnO 
NPs for 24 hours along with untreated control cells were 
analyzed. In control cells, the DNA was not fragmented, 
whereas the cells treated with ZnO NPs had started the 
apoptotic process, as was evident by DNA fragmentation 
(Figure 6D).
ZnO NPs altered the oxidant/ 
antioxidant balance of human  
liver cancer hepg2 cells
It has been suggested that oxidant generation and antioxidant 
depletion are the common pathways through which anticancer 
drugs trigger apoptosis in cancer cells.22 Therefore, the status 
of oxidants and antioxidants was examined in human liver 
cancer HepG2 cells treated with ZnO NPs at the concentra-
tion of 15 µg/mL for 24 hours. ROS and LPO levels were 
measured as markers of oxidants, whereas antioxidant status 
was examined by determining the GSH, SOD, CAT, GPx, 
and GR. Results showed that oxidant (ROS and LPO) levels 
were significantly higher in treated cells (Figure 7A and B) 
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are expressed in relative quantity compared with those for the respective unexposed control cells. (A) p53, (B) bax, (C) bcl-2, and (D) caspase-3. Data represented are 
mean ± standard deviation of three identical experiments made in triplicate.
Note: *Statistically significant difference as compared with the controls (P , 0.05 for each).
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Figure 6 Zinc oxide nanoparticles (ZnO NPs) induced apoptosis in human lung cancer (hepg2) cells. (A) Western blot analysis of p53, bax, bcl-2, and bax proteins in 
hepg2 cells treated with 15 µg/mL ZnO NPs for 24 hours. At the end of exposure, cells were lysed in RIPA buffer and cell extract subjected to Western blots antibodies, as 
described in Materials and methods. Immunoblot images are the representative of three identical experiments. The β-actin blot is a loading control. (B) Protein levels were 
also analyzed by desitometric analysis using AlphaEase TM FC StandAlone V.4.0.0 software. Results are expressed as a fold change over the control group. Bar diagrams are 
from mean ± standard deviation of protein levels from three blots. (C) ZnO NPs induced the activity of Caspase-3 enzyme in hepg2 cells. Caspase-3 data represented are 
mean ± standard deviation of three identical experiments made in triplicate. (D) ZnO NPs induced the apoptotic DNA fragmentation in hepg2 cells treated with 15 µg/mL 
ZnO NPs for 24 hours.
Note: *Statistically significant difference as compared to the controls (P , 0.05 for each).
(P , 0.05 for each). On the other hand, ZnO NPs induced 
GSH depletion (Figure 8A) along with the lower activity of 
antioxidant enzymes GPx, GR, SOD, and CAT in HepG2 cells 
(Figure 8B–E) (P , 0.05 for each).
Discussion
Nanomedicine aims to overcome the problems related to 
human diseases at the nanoscale level, where most of the 
biological molecules exist and operate.42 Physicochemical 
characterization of nanoscale materials is essential in 
biomedical research for better interpretation of results. 
Parameters including shape, size, crystal structure, purity, 
hydrodynamic size, agglomeration, and aqueous stability 
have been suggested for NP characterization.20 UV-Vis 
spectroscopy, XRD, SEM, TEM, EDS, and DLS techniques 
were utilized to characterize the NPs. The band-gap energy 
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calculated from the UV-Vis spectrum of the ZnO NPs was 
3.32 eV . It has been suggested that due to a wide band gap 
(energy donor capacity), ZnO NPs could act as novel pho-
tosensitizers, or at least as potentiators of the conventional 
photosensitizing drugs, in photodynamic therapy of cancer.43 
Recent studies reported that UV irradiation could readily 
enhance the proliferation-suppression ability of ZnO NPs 
on cancer cells.43,44 Our XRD results confirm the crystalline 
nature of ZnO NPs. SEM and TEM showed that NPs were 
polygonal in shape with a smooth surface, were fairly dis-
tributed, and had an average diameter of 21 nm. EDS data 
indicated that synthesized ZnO NPs were highly pure with 
no traces of impurities. Agglomeration and stability of NPs 
in an aqueous state are major concerns in nanomedicine 
research. Once the ZnO NPs were introduced to water or 
cell culture media, the sizes changed to approximately five 
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Figure 7 Zinc oxide nanoparticles (ZnO NPs) induced oxidant generation in human lung cancer (hepg2) cells treated with 15 µg/mL ZnO NPs for 24 hours. At the end 
of treatment, reactive oxygen species (ROS) and malondialdehyde (MDA) levels were determined, as described in Materials and methods. (A) ROS and (B) MDA. Data 
represented are mean ± standard deviation of three identical experiments made in triplicate.
Note: *Statistically significant difference as compared to the controls (P , 0.05 for each).
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Figure 8 Zinc oxide nanoparticles (ZnO NPs) diminished the antioxidant defense system of human lung cancer (hepg2) cells treated with 15 µg/mL ZnO NPs for 24 hours. 
At the end of treatment, glutathione (gSh) level and antioxidant enzyme activity were determined, as described in Materials and methods. (A) gSh, (B) gSh peroxidise 
(gPx), (C) gSh reductase (gR), (D) superoxide dismutase (SOD), and (E) catalase (CAT). Data represented are mean ± standard deviation of three identical experiments 
made in triplicate.
Note: *Statistically significant difference as compared to the controls (P , 0.05 for each).
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to ten times the primary size.45 The average hydrodynamic 
size of the present ZnO NPs in water and cell culture media 
determined by DLS was 131 nm and 127 nm, respectively. 
The higher size of NPs in aqueous suspension as compared 
with TEM and XRD might be due to the tendency of particles 
to agglomerate in an aqueous state. This finding is supported 
by other investigators27,46 and has been briefly discussed in 
our previous publications.47,48 The tendency of particles to 
form aggregates depends strongly on the surface charge. The 
particle charge, determined as zeta potential, was -31 mV 
and -33 mV for water and culture medium, respectively. Zeta 
potential results suggested that ZnO NPs are fairly stable in 
an aqueous state.
One of the major challenges in cancer therapy is to 
improve the selectivity and efficacy of anticancer drugs and 
reduce their side effects to improve quality of life for cancer 
patients.49 The key finding of this investigation was to support 
the hypothesis that ZnO NPs induce toxicity in a cell-specific 
manner. We have observed that ZnO NPs have distinct effects 
on mammalian cell viability via killing cancer cells (HepG2, 
A549, and BEAS-2B) while posing no impact on normal cells 
like rat astrocytes and hepatocytes. Our cytotoxicity results 
are in agreement with recently published studies that reported 
that ZnO NPs significantly induce cytotoxicity to cancer cells, 
and no major effect was observed on normal cells. Ostrovsky 
et al8 have reported that the ZnO NPs exerted cytotoxic effect 
on several human glioma cell lines (A172, U87, LNZ308, 
LN18, and LN229), and no cytotoxic effect was observed on 
normal human astrocytes. ZnO NPs exhibited a preferential 
ability to kill human myeloblastic leukemia cells (HL60) as 
compared with normal peripheral blood mononuclear cells.9 
Hanley et al7 also observed that ZnO NPs exhibit a strong 
preferential ability to kill cancerous T cells compared with 
normal cells. Selective killing of cancer cells by ZnO NPs 
may be of important clinical interest, as one of the greatest 
challenges facing cancer chemotherapy is the inability of 
anticancer drugs to effectively distinguish between normal 
and cancer cells.
The shape of NPs also plays a significant role in the kill-
ing of cancer cells. Nair et al50 showed that rod-shaped ZnO 
NPs exerted lower cytotoxicity as compared with spherical 
ZnO NPs in osteoblast cancer cells. In the present study we 
observed that polygonal ZnO NPs seem to be much more 
cytotoxic to cancer cells than previously reported rod-shaped 
ZnO NPs.18 Polygonal ZnO NPs at the concentration of 
15 µg/mL decreased the cell viability to 33%, 39%, and 
47% for the BEAS-2B, HepG2, and A549 cells, respectively, 
whereas our previous study showed that 100 µg/mL of 
  rod-shaped ZnO NPs was required to reduce 27% viability 
of A549 cancer cells with the same exposure time. It is also 
worth mentioning that present polygonal ZnO NPs were 
synthesized by the coprecipitation method, and previously 
reported rod-shaped ZnO NPs were prepared with the sol-gel 
technique using the same precursor, zinc acetate dihydrate.
We should further consider the stability of the particles 
in cell culture suspension as well as potential concerns about 
the toxicity of dissolved Zn2+ ions. Recent studies have 
shown that Zn2+ is released from the surface of ZnO NPs when 
they are suspended in an aqueous state.46,51 However, in the 
present study, we did not examine the degree of ionization 
of ZnO NPs in an aqueous suspension and their toxicity to 
cancer cells. Several recent studies, along with our previous 
publication, showed that ZnO NPs liberate Zn2+ in an aque-
ous state, but the levels of Zn2+ released were insufficient to 
promote toxicity to cells unless the particulate matter is in 
contact with the cells.18,52,53 Moreover, in a recent investiga-
tion, Kilari et al54 showed the protective effect of Zn2+ in 
colon cancer (Caco-2) cells.
We utilized human liver cancer (HepG2) to explore the 
possible molecular mechanisms of toxicity induced by ZnO 
NPs. We observed that the expressions of both mRNA and 
protein levels of tumor suppressor gene p53 and proapoptotic 
genes (bax and caspase-3) were upregulated while the expres-
sion of antiapoptotic gene bcl-2 was downregulated in cancer 
cells treated with ZnO NPs. In the presence of DNA damage 
or cellular stress, p53 triggers cell-cycle arrest to provide time 
for the damage to be repaired or for self-mediated apoptosis.12 
Gopinath et al55 also showed that bax is upregulated by p53. 
Because an increase in bax expression was observed in this 
study, the role of p53 in the upregulation of bax upon ZnO 
NP treatment can be postulated. Cleavage of DNA at the 
internucleosomal linker sites yielding DNA fragments is 
regarded as a biochemical hallmark of apoptosis.56 Activated 
caspase-3 is capable of autocatalysis as well as cleaving and 
activating other members of the caspase family, leading to 
rapid and irreversible apoptosis.57 In the present study we 
also showed the higher activity of caspase-3 enzyme along 
with the DNA fragmentation in liver cancer cells treated with 
ZnO NPs. Consequently, ZnO NPs show much promise as 
new anticancer agents, given the specific apoptotic response 
of cancer cells, as shown in this work. However, the exact 
difference that resulted in cancer-specific toxicity is still 
largely unclear.
Current developments in cancer research suggest that 
a number of apoptotic stimuli share common mechanistic 
pathways characterized by the generation of ROS through 
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oxidative stress.22,48,58 ROS typically include the superoxide 
radical (O2-), hydrogen peroxide (H2O2), and hydroxyl 
radical (OH), which cause damage to cellular components 
including DNA and proteins.21 In the present study, ZnO NPs 
significantly altered the oxidant/antioxidant status of human 
liver cancer cells. ROS generation and membrane LPO were 
significantly higher, whereas antioxidant molecule GSH and 
the activity of antioxidant enzymes SOD, CAT, GPx, and 
GR were significantly lower in ZnO NP-treated cells. GSH, 
a ubiquitous and abundant cellular antioxidant tripeptide, was 
found to be strongly depleted in response to NP treatment.59 
GR is an important enzyme in recycling the GSSH back 
to GSH. The activity of GPx can provide important clues 
about the consumption rate of GSH during detoxification of 
organic hydroperoxides by it. SOD is specialized to convert 
highly reactive O2- to less toxic H2O2. CAT enzyme reduces 
H2O2 to H2O.60,61 Higher production of intracellular ROS 
and membrane LPO in ZnO NP-treated cancer cells, along 
with depletion of antioxidant components, suggests that 
ROS generation and oxidative stress might be the primary 
mechanisms for toxicity of ZnO NPs to human liver cancer 
HepG2 cells.
Conclusion
We observed that ZnO NPs have distinct effects on mam-
malian cell viability via killing cancer cells (HepG2, A549, 
and BEAS-2B) while posing no effect on normal cells (rat 
astrocytes and hepatocytes). The marked difference in cyto-
toxicity between cancer cells and normal cells suggests an 
exciting potential for ZnO NPs as novel alternatives to cancer 
therapy. Our molecular data showed that both mRNA and 
protein levels of tumor suppressor gene p53 and apoptotic 
gene bax were upregulated while the antiapoptotic gene bcl-2 
was downregulated in ZnO NP-treated human liver cancer 
cell HepG2. ZnO NPs were also found to induce activity of 
caspase-3 enzyme and DNA fragmentation in HepG2 cells. 
Moreover, ZnO NPs induced levels of oxidants (ROS and 
LPO) and reduced the antioxidant capacity of HepG2 cells. 
This study suggests that ZnO NPs induce apoptosis in   cancer 
cells, which is mediated by ROS via p53, bax/bcl-2, and cas-
pase pathways through which most of the anticancer drugs 
trigger apoptosis. Further research on other cancer cells and 
normal cells must be considered to determine whether this is a 
universal mechanism in the anticancer activity of ZnO NPs.
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